Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jan;76(2):189-190.
doi: 10.1111/his.13998.

Programmed death ligand 1 immunohistochemistry: can we agree on this?

Lynette M Sholl  1
Affiliations
Editorial

Programmed death ligand 1 immunohistochemistry: can we agree on this?

Lynette M Sholl. Histopathology. 2020 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Topalian SL, Hodi FS, Brahmer JR et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 2012; 366; 2443-2454.
    1. Brahmer JR, Tykodi SS, Chow LQ et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 2012; 366; 2455-2465.
    1. Garon EB, Hellmann MD, Rizvi NA et al. Five-year overall survival for patients with advanced nonsmall-cell lung cancer treated with pembrolizumab: results from the Phase I KEYNOTE-001 study. J. Clin. Oncol. 2019; 37; 2518-2527.
    1. Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review. Semin. Cancer Biol. 2019. https://doi.org/10.1016/j.semcancer.2019.06.012
    1. Yu Y, Zeng D, Ou Q et al. Association of survival and immune-related biomarkers with immunotherapy in patients with non-small cell lung cancer: a meta-analysis and individual patient-level analysis. JAMA Netw. Open 2019; 2; e196879.